The results showed that the transplantation of BM-MSCs effectively reduced BLM-induced pulmonary fibrosis and that G-CSF pretreatment significantly enhanced the antifibrotic effects of BM-MSCs. This evidence concerns the gene CSF3 and pulmonary fibrosis.